Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

EMERYVILLE, CA US

1. 20110045457 ASSAYS FOR ADSORBED INFLUENZA VACCINES - Influenza hemagglutinin binds to aluminium salt adjuvants and cannot easily be directly assayed directly a 02-24-2011
2. 20110045022 VACCINES INCLUDING ANTIGEN FROM FOUR STRAINS OF INFLUENZA VIRUS 02-24-2011
3. 20110045017 HIV VACCINE FOR MUCOSAL DELIVERY - This invention is directed to pharmaceutical compositions comprising an HIV antigen and a mucosal adjuvant and 02-24-2011
4. 20110045015 CONJUGATED BETA-1,3-LINKED GLUCANS - Glucans having exclusively or mainly 02-24-2011
5. 20110038900 NANOPARTICLES FOR USE IN PHARMACEUTICAL COMPOSITIONS 02-17-2011
6. 20110038879 IMMUNOGENIC AND THERAPEUTIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES 02-17-2011
7. 20110034462 ORGANIC COMPOUNDS - compounds of the formula, and their use in therapy 02-10-2011
8. 20110033485 ANALOGUES OF GLYCOLIPIDS USEFUL AS IMMUNOADJUVANTS 02-10-2011
9. 20110027314 Influenza Vaccines Containing Hemagglutinin and Matrix Proteins 02-03-2011
10. 20110022023 UNITARY WITHDRAWAL SPIKE UNIT SUITABLE FOR FACTORY FITTING 01-27-2011
11. 20110020396 HIV Envelope-CD4 Complexes and Hybrids - Env-CD4 polypeptide complexes and hybrids that expose cryptic epitopes important in virus neutralization are 01-27-2011
12. 20110020390 MENINGOCOCCAL FHBP POLYPEPTIDES - fHBP is a protein in Neisseria meningitidis 01-27-2011
13. 20110020385 COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES 01-27-2011
14. 20110020352 ENDOGENOUS RETROVIRUSES UP-REGULATED IN PROSTATE CANCER 01-27-2011
15. 20110015798 Building Energy Usage Auditing, Reporting, and Visualization 01-20-2011
16. 20110014652 Norovirus and sapovirus antigens - Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described 01-20-2011
17. 20110014230 PREPARATION OF INFLUENZA VIRUS VACCINE ANTIGENS 01-20-2011
18. 20110014219 Norovirus and Sapovirus antigens - Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described 01-20-2011
19. 20110008279 Methods and Compositions Relating to Adhesins as Adjuvants 01-13-2011
20. 20110003300 RAPID STERILITY MICROASSAY - method for detecting a viable microorganism in a pharmaceutical composition comprising the steps of providing a filterable 01-06-2011
21. 20110002958 Alphavirus Vectors for Respiratory Pathogen Vaccines 01-06-2011
22. 20100330121 RECOMBINANT ALPHAVIRUS-BASED VECTORS WITH REDUCED INHIBITION OF CELLULAR MACRO-MOLECULAR SYNTHESIS 12-30-2010
23. 20100324924 Medical Billing Systems and Methods - medical billing systems, software, and methods 12-23-2010
24. 20100324272 PANCREATIC CANCER GENES - the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia 12-23-2010
25. 20100322958 MODIFIED SACCHARIDES - Modified capsular saccharides comprising a blocking group at a hydroxyl group position on at least one of the monosaccharide 12-23-2010
26. 20100316698 POLYNUCLEOTIDES ENCODING ANTIGENIC HIV TYPE C POLYPEPTIDES, POLYPEPTIDES AND USES THEREOF 12-16-2010
27. 20100303864 CONSERVED AND SPECIFIC STREPTOCOCCAL GENOMES 12-02-2010
28. 20100303822 Polypeptides from non-typeable haemophilus influenzae 12-02-2010
29. 20100297164 Chlamydial Antigens - The invention is in the field of immunology and vaccinology 11-25-2010
30. 20100295265 Single-Speed Bicycle Conversion Apparatus, Methods, and Kits 11-25-2010
31. 20100292216 Methods and Compositions for the Treatment of Psychiatric Conditions 11-18-2010
32. 20100291598 PRION ELISA 11-18-2010
33. 20100291134 TRUNCATED HEPATITIS C VIRUS NS5 DOMAIN AND FUSION PROTEINS COMPRISING SAME 11-18-2010
34. 20100291129 Norovirus and sapovirus antigens - Immunogenic compositions that elicit immune responses against Norovirus and Sapovirus antigens are described 11-18-2010
35. 20100285135 Nanoparticles For Use In Immunogenic Compositions 11-11-2010
36. 20100285069 MENINGOCOCCAL VACCINE FORMULATIONS - dual formulation for vaccines against Neisseria meningitidis serogroup B comprises an oil-in-water emulsion 11-11-2010
37. 20100285062 COMBINED MUCOSAL AND PARENTERAL IMMUNIZATION AGAINST HIV 11-11-2010
38. 20100282684 LIPOPOLYSACCHARIDE DECONTAMINATION - Materials and methods for the selective removal of lipopolysaccharide during the purification of molecules of 11-11-2010
39. 20100280154 Wood Treatment Composition and Process - The present invention comprises a fire resistant wood product and method of manufacture thereof 11-04-2010
40. 20100272755 FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM 10-28-2010
41. 20100272725 Neisserial antigens - The invention provides proteins from Neisseria meningitidis and from Neisseria gonorrhoeae including amino acid sequences 10-28-2010
42. 20100269440 Roof tiles and roof tile structures and methods of making same 10-28-2010
43. 20100267931 HETEROLOGOUS EXPRESSION OF NEISSERIAL PROTEINS 10-21-2010
44. 20100266631 Compositions and Methods for Generating an Immune Response Utilizing Alphavirus-Based Vector Systems 10-21-2010
45. 20100266626 ADJUVANTED GLUCANS - The use of beta-glucans as antigens for immunising against fungi is known 10-21-2010
46. 20100256637 Laparoscopic Nephrectomy Device - is disclosed 10-07-2010
47. 20100256375 SUBSTITUTED BENZIMIDAZOLES AND METHODS OF PREPARATION 10-07-2010
48. 20100255002 Immunogenic compositions for chlamydia trachomatis 10-07-2010
49. 20100253934 ANALYSIS OF MIXTURES INCLUDING PROTEINS - The quality control of vaccines is an important step in the release of vaccines to patients 10-07-2010
50. 20100239607 COMPOSITIONS FOR INDUCING IMMUNE RESPONSES 09-23-2010
51. 20100239600 CONJUGATE PURIFICATION - This application relates to methods for the purification of saccharide antigen-carrier protein conjugates 09-23-2010
52. 20100235341 Methods and Systems for Searching Using Spoken Input and User Context Information 09-16-2010
53. 20100234394 SUBSTITUTED BENZIMIDAZOLES AND METHODS OF THEIR USE 09-16-2010
54. 20100233205 ADJUVANTED ANTIGENIC MENINGOCOCCAL COMPOSITIONS 09-16-2010
55. 20100233187 GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS 09-16-2010
56. 20100229780 Modular Removable Console for a Boat - removable console for a boat and a boat including such a removable console are disclosed 09-16-2010
57. 20100228540 Methods and Systems for Query-Based Searching Using Spoken Input 09-09-2010
58. 20100227311 TISSUE CULTURE SYSTEM FOR PRODUCTION OF HEPATITIS C VIRUS 09-09-2010
59. 20100226937 COMBINATION VACCINES WITH 1-HYDROXY-2-PHENOXYETHANE PRESERVATIVE 09-09-2010
60. 20100226931 Compounds for immunopotentiation - Methods of stimulating an immune response and treating patients responsive thereto with 3 4-di-1H-pyrrole-2 09-09-2010
61. 20100221278 IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES 09-02-2010
62. 20100221256 MENINGOCOCCUS ADHESINS NADA, APP AND ORF 40 09-02-2010
63. 20100219335 Liquid Chromatography-Mass Spectrometry Analysis of Samples Using Ionic Eluent Comprising a Volatile Ionic Salt 09-02-2010
64. 20100215683 PROTECTIVE ANTIGENS FOR GROUP B STREPTOCOCCUS HYPERVIRULENT STRAINS 08-26-2010
65. 20100205017 Automated Transportation Call-Taking System 08-12-2010
66. 20100203501 Assay to detect HCV receptor binding - Identification of HCV receptor target cells using HCV receptor-binding ligands and cell separation by flow 08-12-2010
67. 20100203137 FORMULATION OF MENINGITIS VACCINES - liquid Hib component is used to reconstitute a lyophilised meningococcal component, thereby producing a combined 08-12-2010
68. 20100203074 COMPOSITIONS AND METHODS FOR TREATING INTRACELLULAR DISEASES 08-12-2010
69. 20100196934 PRION ASSAY - assay method for detecting the presence of PrP 08-05-2010
70. 20100196368 SUBSTITUTED BENZ-AZOLES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE 08-05-2010
71. 20100196339 Microparticle-Based Transfection and Activation of Dendritic Cells 08-05-2010
72. 20100189737 Meningococcal vaccines including hemoglobin receptor 07-29-2010
73. 20100183674 COMPOSITIONS COMPRISING YERSINIA PESTIS ANTIGENS 07-22-2010
74. 20100183671 LOW-ADDITIVE INFLUENZA VACCINES - influenza vaccine that lacks at least three of a mercurial preservative 07-22-2010
75. 20100183653 Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof 07-22-2010
76. 20100177992 Compressible and Storable Bags and Items 07-15-2010
77. 20100173412 Eukaryotic Layered Vector Initiation Systems 07-08-2010
78. 20100166788 IMMUNOGENS FROM UROPATHOGENIC ESCHERICHIA COLI 07-01-2010
79. 20100166716 Colony-forming unit cell of human chorion and method to obtain and use thereof 07-01-2010
80. 20100160431 Methods and Compositions for the Treatment of Viral Infections 06-24-2010
81. 20100158943 ADMINISTRATION ROUTES FOR PRIMING/BOOSTING WITH INFLUENZA VACCINES 06-24-2010
82. 20100158940 MANUFACTURE OF BOOSTER VACCINES HAVING REDUCED ANTIGEN DOSES 06-24-2010
83. 20100158935 MUTANT FORMS OF STREPTOLYSIN O - Forms of GAS25 which are not toxic but which still maintain the ability to induce protection against S 06-24-2010
84. 20100150943 IMMUNOGENIC COMPOSITIONS FOR GRAM POSITIVE BACTERIA 06-17-2010
85. 20100150912 BLOCKING INTERACTION BETWEEN PATHOGEN FACTORS AND FACTOR H TO INHIBIT HEMORRHAGIC SYNDROMES 06-17-2010
86. 20100143418 Immunising Against Meningococcal Serogroup Y Using Proteins 06-10-2010
87. 20100143293 T cell activation - method for antigen independent activation of T cells comprising contacting T cells with a combination of cytokines such as two or 06-10-2010
88. 20100136522 ENDOGENOUS RETROVIRUSES UP-REGULATED IN PROSTATE CANCER 06-03-2010
89. 20100136041 COMBINATION GAS VACCINES AND THERAPEUTICS 06-03-2010
90. 20100129826 Double stranded RNA receptor (dsRNA-R) and methods relating thereto 05-27-2010
91. 20100119093 PERSONAL LISTENING DEVICE WITH AUTOMATIC SOUND EQUALIZATION AND HEARING TESTING 05-13-2010
92. 20100114058 MULTIDOSE VIAL ASSEMBLIES AND ADAPTERS THEREFOR 05-06-2010
93. 20100107514 Methods and apparatus for a building roof structure 05-06-2010
94. 20100105875 Antibodies against neisserial factor H binding protein 04-29-2010
95. 20100105865 Nucleic acids and proteins from streptococcus groups a & b 04-29-2010
96. 20100104593 MENINGOCOCCAL CONJUGATE VACCINATION - Conjugated meningococcal capsular saccharides will be introduced into immunisation schedules in the near future 04-29-2010
97. 20100098718 NUCLEIC ACID VECTORS FOR IMMUNIZATION - dimeric protein comprising a first fusion protein and a second fusion protein wherein the first fusion protein 04-22-2010
98. 20100098697 Chlamydia trachomatis antigens - Proteins encoded by Chlamydia trachomatis which are immunogenic in humans as a consequence of infection have been 04-22-2010
99. 20100094891 Client-Server System for Multi-Resource Searching 04-15-2010
100. 20100092509 Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides 04-15-2010
101. 20100092503 HCV FUSION POLYPEPTIDEDS - The invention provides HCV fusion polypeptides including truncated or full-length HCV NS5 polypeptides 04-15-2010
102. 20100092502 MODIFIED HIV ENV POLYPEPTIDES - Polynucleotide encoding modified HIV Env polypeptides are disclosed 04-15-2010
103. 20100086906 Obstructed Delivery Simulation System - Maternal and fetal birthing simulators are disclosed 04-08-2010
104. 20100086565 Vectors for expression of hml-2 polypeptides 04-08-2010
105. 20100078252 Vehicle Passenger Restraint System - is disclosed 04-01-2010
106. 20100075965 PI3 KINASE INHIBITORS AND METHODS OF THEIR USE 03-25-2010
107. 20100074923 PURIFICATION OF BACTERIAL ANTIGENS - Presented are methods of isolation of pili and pilus-like structures from Gram-positive bacteria including 03-25-2010
108. 20100068223 Storage of Influenza Vaccines Without Refrigeration 03-18-2010
109. 20100068219 PEPTIDES THAT MIMIC NON-HUMAN CROSS-REACTIVE PROTECTIVE EPITOPES OF THE GROUP B MENINGOCOCCAL CAPSULAR POLYSACCHARIDE 03-18-2010
110. 20100063270 Purification of Streptococcal Capsular Polysaccharide 03-11-2010
111. 20100062977 TCR-Independent Activation of T Cells - method for TCR-independent T cell activation which comprises the co-ligation of CD28 and CD81 03-11-2010
112. 20100056447 IMMUNIZATION AGAINST CHLAMYDIA PNEUMONIAE 03-04-2010
113. 20100055130 STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS 03-04-2010
114. 20100055128 METHOD FOR THE PURIFICATION OF ALPHAVIRUS REPLICON PARTICLES 03-04-2010
115. 20100048561 QUINAZOLINES FOR PDK1 INHIBITION - The invention provides quinazoline compounds that are inhibitors of PDK1 02-25-2010
116. 20100047342 Method and Composition for Administering an NMDA Receptor Antagonist to a Subject 02-25-2010
117. 20100047273 Coxsackie B virus and type 1 diabetes - Type 1 diabetes mellitus is characterized by loss of pancreatic insulin-producing beta cells, resulting in 02-25-2010
118. 20100047267 Staphylococcus aureus proteins and nucleic acids 02-25-2010
119. 20100041868 Conserved neisserial antigens - To ensure maximum cross-strain recognition and reactivity regions of proteins that are conserved between different 02-18-2010
120. 20100040676 POLYCISTRONIC HIV VECTOR CONSTRUCTS - The present disclosure relates to vectors comprising polynucleotide sequences that encode HIV polypeptides 02-18-2010
121. 20100036660 Emotion Detection Device and Method for Use in Distributed Systems 02-11-2010
122. 20100035285 RAPID ELISA - step in the enzyme-linked immunosorbent assay is changed from a heterogeneous phase to a homogeneous phase 02-11-2010
123. 20100035234 VACCINE ASSAYS - methods assays and compositions for implementing such methods and assays for assessing efficacy of individual components in 02-11-2010
124. 20100034847 Multiple vaccination including Serogroup C Meningococcus 02-11-2010
125. 20100034844 Activation of HCV Specefic T Cells - Methods for activating HCV-specific T cells are described 02-11-2010
126. 20100034830 Rabies vaccine - The invention provides for an immunogenic rabies vaccine comprising a reduced vaccine dose and methods of pre- and post-exposure 02-11-2010
127. 20100034822 Haemophilus Influenzae Type B - Polypeptides comprising various amino acid sequences derived from Haemophilus influenzae type b, including a number of 02-11-2010
128. 20100034813 SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS 02-11-2010
129. 20100029665 Methods and Compositions for Treating Migraine Pain 02-04-2010
130. 20100024655 Range Hood with Liquid Filter - range hood for a kitchen range or other similar appliance is disclosed 02-04-2010
131. 20100022659 Methods and Compositions for the Treatment of CNS-Related Conditions 01-28-2010
132. 20100022015 Analysis of Mannosamine-containing Capsular Saccharides 01-28-2010
133. 20100021548 USE OF MICROPARTICLES WITH ADSORBED ANTIGEN TO STIMULATE IMMUNE RESPONSES 01-28-2010
134. 20100017895 Small animal model for hcv replication - animal model for HCV replication and/or production of virus or virus like particles is provided 01-21-2010
135. 20100015320 Natural sugar replacement and process for preparing the same 01-21-2010
136. 20100015212 IMMUNOGENIC BACTERIAL VESICLES WITH OUTER MEMBRANE PROTEINS 01-21-2010
137. 20100015168 IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS AGALACTIAE 01-21-2010
138. 20100015151 POLYPEPTIDES FROM NEISSERIA MENINGITIDIS 01-21-2010
139. 20100010217 METHODS FOR THE PREPARATION OF IMIDAZOLE-CONTAINING COMPOUNDS 01-14-2010
140. 20100010199 MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS 01-14-2010
141. 20100005081 Systems for natural language processing of sentence based queries 01-07-2010
142. 20100004253 BIOMARKERS OF TARGET MODULATION, EFFICACY, DIAGNOSIS AND/OR PROGNOSIS FOR RAF INHIBITORS 01-07-2010
143. 20100003280 Adjuvant compositions - comprising type 1 interferon inducers such as double-stranded RNA in combination with antigen delivery systems and/or 01-07-2010
144. 20090327170 Methods of Clustering Gene and Protein Sequences 12-31-2009
145. 20090326978 Emergency Preparations for an Epidemic - Stockpiles and methods of stockpiling a combination antiviral therapy for responding to an epidemic viral 12-31-2009
146. 20090324633 Immunogens from Uropathogenic Escherichia Coli 12-31-2009
147. 20090318879 SYRINGE ACCESORY DEVICE - syringe accessory device for adjustment of a predefined partial syringe dosage comprises a recess for receiving a syringe body 12-24-2009
148. 20090317420 Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae 12-24-2009
149. 20090317359 2,6-DISUBSTITUTED QUINAZOLINES, QUINOXALINES, QUINOLINES AND ISOQUINOLINES AND METHODS OF THEIR USE AS INHIBITORS OF RAF KINASE 12-24-2009
150. 20090311288 IMIDAZOQUINOXALINE COMPOUNDS AS IMMUNOMODULATORS 12-17-2009
151. 20090306051 Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders 12-10-2009
152. 20090305344 CHIMERIC ALPHAVIRUS REPLICON PARTICLES - Chimeric alphaviruses and alphavirus replicon particles are provided, including methods of making and using 12-10-2009
153. 20090304745 CHIMERIC ALPHAVIRUS REPLICON PARTICLES - Chimeric alphavirus particles and alphavirus replicon RNAs are provided including methods of making and using 12-10-2009
154. 20090304743 Composition and Methods for Immunisation Using CD1D Ligands 12-10-2009
155. 20090304740 MODIFIED HIV ENV POLYPEPTIDES - Polynucleotide encoding modified HIV Env polypeptides are disclosed 12-10-2009
156. 20090304739 INFLUENZA VACCINES INCLUDING COMBINATIONS OF PARTICULATE ADJUVANTS AND IMMUNOPOTENTIATORS 12-10-2009
157. 20090304729 CELL-DERIVED VIRAL VACCINES WITH LOW LEVELS OF RESIDUAL CELL DNA 12-10-2009
158. 20090298099 Gonococcal Proteins and Nucleic Acids - The invention provides proteins from gonococcus including amino acid sequences the corresponding nucleotide 12-03-2009
159. 20090297553 Regimens for Immunisation With Meningococcal Conjugates 12-03-2009
160. 20090297549 CONSERVED AND SPECIFIC STREPTOCOCCAL GENOMES 12-03-2009
161. 20090297542 Adp-ribosylating toxin from listeria monocytogenes 12-03-2009
162. 20090297507 ADAM10 in Cancer Diagnosis, Detection and Treatment 12-03-2009
163. 20090291103 QUALITY CONTROL METHODS FOR OIL-IN-WATER EMULSIONS CONTAINING SQUALENE 11-26-2009
164. 20090285854 FROZEN STOCKPILING OF INFLUENZA VACCINES 11-19-2009
165. 20090285849 Thiosemicarbazones as anti-virals and immunopotentiators 11-19-2009
166. 20090285845 Domains And Epitopes Of Meningococcal Protein NMB1870 11-19-2009
167. 20090282588 Methods for Reducing Leaf Senescence Using Methyl Dihydrojasmonate 11-12-2009
168. 20090258033 HCV E1E2 vaccine compositions - HCV E1E2 compositions comprising E1E2 antigens, submicron oil-in-water emulsions and/or immunostimulatory nucleic acid 10-15-2009
169. 20090253728 Methods and Compositions for Treating Nociceptive Pain 10-08-2009
170. 20090252738 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix 10-08-2009
171. 20090247481 Compositions and Kits for Treating Influenza 10-01-2009
172. 20090239922 Kinesin inhibitors as cancer therapeutics 09-24-2009
173. 20090239240 Mutant Forms of Fas Ligand and Uses Thereof 09-24-2009
174. 20090238841 HIV VACCINE FORMULATIONS - Provided herein are HIV vaccines comprising HIV polypeptide-encoding DNA adsorbed to PLG and/or HIV proteins 09-24-2009
175. 20090232844 IMMUNOPOTENTIATING COMPOUNDS - The invention provides novel compositions comprising Imidazopyridine compounds 09-17-2009
176. 20090232820 NEISSERIA MENINGITIDIS ANTIGENS AND COMPOSITIONS 09-17-2009
177. 20090220547 Reducing interference between oil-containing adjuvants and surfactant-containing antigens 09-03-2009
178. 20090220546 Adjuvanted influenza vaccines for pediatric use 09-03-2009
179. 20090220545 Adjuvant-Sparing Multi-Dose Influenza Vaccination Regimen 09-03-2009
180. 20090220544 ADJUVANTED VACCINES WITH NON-VIRION ANTIGENS PREPARED FROM INFLUENZA VIRUSES GROWN IN CELL CULTURE 09-03-2009
181. 20090220541 EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES 09-03-2009
182. 20090217928 Powder aerosolization apparatus and method 09-03-2009
183. 20090214592 Adjuvant composition comprising aluminium phosphate and 3D-MPL 08-27-2009
184. 20090214586 Combination Vaccines With Whole Cell Pertussis Antigen 08-27-2009
185. 20090214537 Serum Resistance Factors of Gram Positive Bacteria 08-27-2009
186. 20090214536 CACNA1E in Cancer Diagnosis, Detection and Treatment 08-27-2009
187. 20090208530 HIV polynucleotides and polypeptides derived from Botswana MJ4 08-20-2009
188. 20090208526 Combination vaccines with low dose of hib conjugate 08-20-2009
189. 20090208523 Adjuvant for vaccines - Vaccine containing a first vaccine, adjuvated with an oil-in-water emulsion comprising 5% squalene 08-20-2009
190. 20090202983 Method For Determining The Concentration of Virus Particles/Virus Antigens 08-13-2009
191. 20090202590 INFLUENZA VACCINES EXTEMPORANEOUSLY ADSORBED TO ALUMINIUM ADJUVANTS 08-13-2009
192. 20090202589 FERMENTER SYSTEM FOR BIOTECHNICAL PROCESSES 08-13-2009
193. 20090192894 Methods and apparatus for creating and managing green micro credits 07-30-2009
194. 20090191536 Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same 07-30-2009
195. 20090191238 Method for producing yeast expressed HPV types 6 and 16 capsid proteins 07-30-2009
196. 20090182129 Capsular Polysaccharide Solubilisation and Combination Vaccines 07-16-2009
197. 20090182128 Capsular Polysaccharide Solubilisation and Combination Vaccines 07-16-2009
198. 20090181049 Capsular polysaccharide solubilisation and combination vaccines 07-16-2009
199. 20090176699 Inhibitors Based on Fusion, Hr1 and Hr2 Sequences in Bacterial Adhesin 07-09-2009
200. 20090176311 SEPARATION OF CONJUGATED AND UNCONJUGATED COMPONENTS 07-09-2009
201. 20090175904 Expressing hepatitis B virus surface antigen for vaccine preparation 07-09-2009
202. 20090171082 MITOTIC KINESIN INHIBITORS - compounds that are useful for treating cellular proliferative diseases 07-02-2009
203. 20090170904 Substituted benzimidazoles and methods of their use 07-02-2009
204. 20090169636 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions 07-02-2009
205. 20090162392 MUTANT FORMS OF STREPTOLYSIN O - Forms of GAS25 which are not toxic but which still maintain the ability to induce protection against S 06-25-2009
206. 20090155306 Pamps, pathogen associated molecular patterns 06-18-2009
207. 20090155305 Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant 06-18-2009
208. 20090155276 NOVEL DKKL-1 Splice Product Modulators for Cancer Diagnosis and Therapy 06-18-2009
209. 20090142261 EPHB3-Specific Antibody and Uses Thereof 06-04-2009
210. 20090136547 ZWITTERIONIZATION OF CAPSULAR SACCHARIDES 05-28-2009
211. 20090133166 Methods for Improving Flowering Characteristics Using Methyl Dihydrojasmonate 05-21-2009
212. 20090130774 Elisa assays using prion-specific peptide reagents 05-21-2009
213. 20090130762 Activation of HCV-specific T cells - method of activating hepatitis C virus -specific T cells, including CD4 05-21-2009
214. 20090130147 Capsular polysaccharide solubilisation and combination vaccines 05-21-2009
215. 20090130146 COMBINATION VACCINE - the combination of antigens directed against bacteria and viruses 05-21-2009
216. 20090130141 Compositions and methods for stimulating an immune response against infectious agents 05-21-2009
217. 20090130140 Capsular Polysaccharide Solubilisation and Combination Vaccines 05-21-2009
218. 20090120752 Collapsible Expanding Luggage - collapsible piece of luggage is disclosed 05-14-2009
219. 20090117148 Capsular Polysaccharides Solubilisation and Combination Vaccines 05-07-2009
220. 20090117113 Immunogenic And Therapeutic Compositions For Streptococcus Pyogenes 05-07-2009
221. 20090114494 Collapsible Expanding Luggage - collapsible piece of luggage is disclosed 05-07-2009
222. 20090106847 System and Method for Media Rights Transfer 04-23-2009
223. 20090104271 Use of microparticles combined with submicron oil-in-water emulsions 04-23-2009
224. 20090104226 Alphavirus Vectors for Respiratory Pathogen Vaccines 04-23-2009
225. 20090104218 Group B Streptococcus - Polypeptides and nucleic acids from Streptococcus agalactiae which can be used in the development of vaccines 04-23-2009
226. 20090104193 SEMA4D in Cancer Diagnosis, Detection and Treatment 04-23-2009
227. 20090099343 Isolation of pathogenic prions - Peptide reagents that interact preferentially with the PrP 04-16-2009
228. 20090098157 Helicobacter Pylori Vaccination - sterile immunogenic preparation of three purified H 04-16-2009
229. 20090098156 Regimens for immunisation with meningococcal conjugates 04-16-2009
230. 20090098153 Activation of HCV-specific T cells - method of activating hepatitis C virus -specific T cells, including CD4 04-16-2009
231. 20090093400 Truncated keratinocyte growth factor (KGF) having increased biological activity 04-09-2009
232. 20090087447 Novel HCV non-structural polypeptide - Polypeptides comprising a mutant non-structural Hepatitis C virus useful in diagnostic and/or immunogenic 04-02-2009
233. 20090082453 Exogenous Methyl Dihydrojasmonate for Prevention and Control of Biotic Attack in Plants 03-26-2009
234. 20090081254 HIV VACCINE FOR MUCOSAL DELIVERY - This invention is directed to pharmaceutical compositions comprising an HIV antigen and a mucosal adjuvant and 03-26-2009
235. 20090081252 DECREASING POTENTIAL IATROGENIC RISKS ASSOCIATED WITH INFLUENZA VACCINES 03-26-2009
236. 20090074886 GSK-3 INHIBITORS - This invention relates to methods of treating or preventing bone loss by administering to a human or animal subject pyrimidine and 03-19-2009
237. 20090070345 Method and apparatus for data storage using striping specification identification 03-12-2009
238. 20090069642 Wearable Wireless Electronic Patient Data Communications and Physiological Monitoring Device 03-12-2009
239. 20090061462 Prion-specific peptide reagents - Peptide reagents that interact preferentially with the PrP 03-05-2009
240. 20090060945 Integration of meningococcal conjugate vaccination 03-05-2009
241. 20090047353 CHANGING TH1/TH2 BALANCE IN SPLIT INFLUENZA VACCINES WITH ADJUVANTS 02-19-2009
242. 20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof 02-19-2009
243. 20090047293 Compositions Comprising Yersinia Pestis Antigens 02-19-2009
244. 20090043077 Conjugation of streptococcal capsular saccharides 02-12-2009
245. 20090035326 COMPOSITIONS WITH ANTIGENS ADSORBED TO CALCIUM PHOSPHATE 02-05-2009
246. 20090031654 Methods and apparatus for controlling moisture in straw bale core walls 02-05-2009
247. 20090028858 SUBSTITUTED QUINOLINE DERIVATIVES - new substituted quinoline compounds and pharmaceutically acceptable salts 01-29-2009
248. 20090025098 Hepatitis C receptor protein CD81 - the use of CD81 protein and polynucleic acid in the therapy and diagnosis of hepatitis C and pharmaceutical 01-22-2009
249. 20090004733 POLYNUCLEOTIDES ENCODING ANTIGENIC HIV TYPE B POLYPEPTIDES, POLYPEPTIDES, AND USES THEREOF 01-01-2009
250. 20090004222 Influenza Vaccination - Influenza viruses have traditionally been administered by intramuscular injection 01-01-2009
251. 20080318275 Hepatitis C virus asialoglycoproteins - Two Hepatitis C Virus envelope proteins are expressed without sialylation 12-25-2008
252. 20080317779 Hiv Tat-Cd4 Hybrid Molecules and Methods of Use Thereof 12-25-2008
253. 20080317744 Indole and Benzimidazole Derivatives - new indole and benzimidazole compounds and pharmaceutically acceptable salts 12-25-2008
254. 20080317660 Nanotube Structures, Materials, and Methods 12-25-2008
255. 20080312137 Fed Batch Culture Methods for Streptococci 12-18-2008
256. 20080311158 Hepatitis C Virus Replication System - cell including: a hepatitis C virus genome and/or nucleic acid encoding a hepatitis C virus genome 12-18-2008
257. 20080305126 Separation of Unconjugated and Conjugated Saccharide by Solid Phase Extraction 12-11-2008
258. 20080305112 IMMUNISATION AGAINST CHLAMYDIA TRACHOMATIS 12-11-2008
259. 20080300385 Covalently-linked complexes of HIV Tat and Env proteins 12-04-2008
260. 20080299561 Novel therapeutic targets in cancer - novel sequences for use in detection, diagnosis and treatment of cancers, especially lymphomas 12-04-2008
261. 20080299544 Hcv Multiple Epitope Fusion Antigens With Modified Proteolytic Cleavage Sites And Uses Thereof 12-04-2008
262. 20080294036 Surgical Metal Detection Apparatus and Methods 11-27-2008
263. 20080292835 Methods for forming freestanding nanotube objects and objects so formed 11-27-2008
264. 20080292655 ENHANCEMENT OF THE IMMUNE RESPONSE FOR VACCINE AND GENE THERAPY APPLICATIONS 11-27-2008
265. 20080292620 PRLR-Specific Antibody and Uses Thereof - PRLR-specific antibodies are provided along with pharmaceutical compositions containing such antibody 11-27-2008
266. 20080287682 Substituted benzimidazoles and methods of preparation 11-20-2008
267. 20080286300 Analysis of Saccharide Vaccines Without Interference 11-20-2008
268. 20080286279 Treatment of Severe Community-Acquired Pneumonia by Administration of Tissue Factor Pathway Inhibitor (Tfpi) 11-20-2008
269. 20080281084 Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway Inhibitor 11-13-2008
270. 20080279819 Combinations Therapy for Treatment of Demyelinating Conditions 11-13-2008
271. 20080274467 Novel Therapeutic Targets in Cancer - novel sequences for use in detection, diagnosis and treatment of cancers, especially lymphomas 11-06-2008
272. 20080274141 ANIMAL CELLS AND PROCESSES FOR THE REPLICATION OF INFLUENZA VIRUSES 11-06-2008
273. 20080274135 Measuring Degree of Polymerisation for Meningococcal Capsular Saccharides That Contain Sialic Acid 11-06-2008
274. 20080274111 Pancreatic Cancer Genes - the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia 11-06-2008
275. 20080269148 Modified Small Interfering Rna Molecules and Methods of Use 10-30-2008
276. 20080267966 Polypeptides from Non-Typeable Haemophilus Influenzae 10-30-2008
277. 20080261271 EXPRESSION OF HIV POLYPEPTIDES AND PRODUCTION OF VIRUS-LIKE PARTICLES 10-23-2008
278. 20080260773 Saccharide Conjugate Vaccines - The invention provides compositions comprising a combination of two or more monovalent conjugates 10-23-2008
279. 20080260769 Polypeptides for Oligomeric Assembly of Antigens 10-23-2008
280. 20080258710 Analysis of Liquid Chromatography Eluates 10-23-2008
281. 20080255120 SUBSTITUTED 2,5-HETEROCYCLIC DERIVATIVES 10-16-2008
282. 20080254065 Influenza Virus Vaccines - vaccine for protecting a human patient against infection by a human influenza virus strain 10-16-2008
283. 20080254057 Combined Meningococcal Conjugates With Common Carrier Protein 10-16-2008
284. 20080249112 Mitotic Kinesin Inhibitors - compounds that are useful for treating cellular proliferative diseases 10-09-2008
285. 20080248059 Dimensional Analysis of Saccharide Conjugates with Gpc & Sec-Mals 10-09-2008
286. 20080241180 Liquid Vaccines For Multiple Meningococcal Serogroups 10-02-2008
287. 20080241067 Methods of Modulating Metastasis and Skeletal Related Events Resulting From Metastases 10-02-2008
288. 20080233046 Trefoil Factor 3 (Tff3) as a Target for Anti-Cancer Therapy 09-25-2008
289. 20080228790 Data storage and retrieval system - user based computer system for information storage and retrieval in which information data items are stored in a 09-18-2008
290. 20080228045 Multiprotocol Wireless Medical Monitors and Systems 09-18-2008
291. 20080227743 Compositions and Kits for Treating Influenza 09-18-2008
292. 20080226598 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems 09-18-2008
293. 20080220010 Immunogenic Compositions for Streptococcus Agalactiae 09-11-2008
294. 20080219968 Sos1 inhibitors - Inhibitors of human Sos1, including antisense oligonucleotides, methods, and compositions specific for human Sos1, are provided 09-11-2008
295. 20080214481 Methods of Treatment of Endobronchial Infections 09-04-2008
296. 20080213308 Imidazoquinoline Compounds - The invention provides novel compositions comprising imidazoquinoline compounds 09-04-2008
297. 20080207589 CYCLIZED DERIVATIVES AS EG-5 INHIBITORS - new substituted imidazole compounds have the following Formula and to the pharmaceutically acceptable salts 08-28-2008
298. 20080200462 SUBSTITUTED PYRAZOLE AND TRIAZOLE COMPOUNDS AS KSP INHIBITORS 08-21-2008
299. 20080200378 KGF polypeptide compositions - Compositions comprising keratinocyte growth factor polypeptides and methods of using the same are described 08-21-2008
300. 20080199492 Env Polypeptide Complexes and Methods Of Use 08-21-2008
301. 20080199487 Glycosylceramide Adjuvant for Saccharide Antigens 08-21-2008